Stocks Health care ESTA
NASDAQ · Health careEstablishment Labs Holdings Inc. (ESTA)
Establishment Labs Holdings Inc. brought in $264M of revenue over the twelve months to September 30, 2026, up 38.3% from a year earlier. It posted a net loss of $38.5M. In fiscal 2025 capital spending exceeded operating cash flow by $56.9M. At September 30, 2026 it held $75.8M in cash against $267.8M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 6, 2026.
Key facts about Establishment Labs Holdings Inc.
- Net worth
- Establishment Labs Holdings Inc. has a market value (market cap) of $2B at the latest share price, and shareholders' equity of $15.6M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $211.1M (+27.1% year on year), with a net loss of $51.1M. Over the 12 months to September 30, 2026: revenue $264M, net loss $38.5M.
- Cash flow
- In fiscal 2025 operations used $50.9M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 6, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
- Next earnings report
- Establishment Labs Holdings Inc.'s next report is expected around January 11, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
What Establishment Labs Holdings Inc. does
Establishment Labs Holdings Inc. is registered with the SEC under industry code SIC 3842 (Orthopedic, Prosthetic & Surgical Appliances & Supplies). Its shares trade on NASDAQ under the ticker ESTA.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $211.1M | -$51.1M | -$1.72 | -$56.9M |
| 2024 | $166M | -$84.6M | -$3.00 | -$64.6M |
| 2023 | $165.2M | -$78.5M | -$3.07 | -$96.4M |
| 2022 | $161.7M | -$75.2M | -$3.08 | -$55M |
| 2021 | $126.7M | -$41.1M | -$1.72 | -$30M |
| 2020 | $84.7M | -$38.1M | -$1.63 | -$14.6M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where ESTA ranks in Health care
Latest SEC filings
What Establishment Labs Holdings Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 6, 2026Quarterly report 10-Q · period to September 30, 2026Revenue rose 34% to $72M versus the same quarter last year; diluted EPS -$0.35 versus -$0.38.
- October 29, 2026
- October 15, 2026
- August 7, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 32% to $67.5M versus the same quarter last year; diluted EPS -$0.39 versus -$0.57.
- August 6, 2026
- July 31, 2026Passive stake (5% or more) SCHEDULE 13G
- July 28, 2026Passive stake (5% or more) SCHEDULE 13G
- June 29, 2026
- May 22, 2026
- May 15, 2026Passive stake changed SCHEDULE 13G/A
Insider trades
What the people running Establishment Labs Holdings Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider bought or sold shares on the open market in the last 90 days. The 6 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| September 30, 2026 | Schutter Edward JDirector | Received as pay | 253 | $16.2K |
| September 30, 2026 | Lewin Nicholas SheridanDirector | Received as pay | 389 | $25K |
| September 30, 2026 | Slotkin BryanDirector | Received as pay | 253 | $16.2K |
| September 30, 2026 | Gillin LeslieDirector | Received as pay | 262 | $16.8K |
| September 30, 2026 | Custin AnnDirector | Received as pay | 301 | $19.3K |
| August 20, 2026 | Caldini FilippoChief Executive Officer, Director | Shares withheld for tax | 682 | $48.8K |
| June 30, 2026 | Schutter Edward JDirector | Received as pay | 216 | $18.5K |
| June 30, 2026 | Lewin Nicholas SheridanDirector | Received as pay | 291 | $25K |
Who owns ESTA
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| RTW Investments, LP13G, passive with 1 related filers | 9.99% | February 14, 2025 |
| JW Asset Management, LLC13G, passive with 4 related filers | 9.15% | July 31, 2026 |
| Qatar Investment Authority13G, passive | 8.27% | May 13, 2025 |
| Brown Advisory Inc13G, passive with 3 related filers | 5.38% | May 15, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 197 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| JW Asset Management, LLC | 2,692,856 | -368,838 |
| Rtw Investments, LP | 2,655,695 | 0 |
| BlackRock, Inc. | 1,582,005 | +1,454,482 |
| Brown Advisory Inc | 1,313,148 | -213,724 |
| Findell Capital Management LLC | 1,096,000 | +98,253 |
| Mudita Advisors LLP | 723,063 | -41,500 |
| William Blair Investment Management, LLC | 714,051 | +25,124 |
| Rubric Capital Management LP | 688,325 | new |
| Nantahala Capital Management, LLC | 671,660 | -161,296 |
| Franklin Resources Inc | 613,698 | +374,484 |
| Bank of America Corp | 608,040 | +191,200 |
| Tyro Capital Management LLC | 605,559 | -545,750 |
| D. E. Shaw & Co., Inc. | 566,910 | +159,129 |
| Rice Hall James & Associates, LLC | 560,935 | +12,261 |
| UBS Group AG | 548,960 | +401,303 |
| Toronto Dominion Bank | 540,024 | 0 |
| Summit Partners Public Asset Management, LLC | 491,486 | +98,681 |
| Royce & Associates LP | 472,316 | +44,844 |
| State Street Corp | 455,315 | +410,185 |
| Two Sigma Investments, LP | 448,425 | +16,940 |
Insiders
11 insiders reported holding 5,287,776 shares in total, about $356.1M at the last price.
| Holder | Shares |
|---|---|
| JW Asset Management, LLCSee footnote 3 | 2,890,5822,890,582 held indirectly |
| Lewin Nicholas SheridanDirector | 1,080,349 |
| Chacon Quiros Juan JoseDirector | 984,012927,504 held indirectly |
| Schutter Edward JDirector | 178,205 |
| Caldini FilippoChief Executive Officer, Director | 48,829 |
| Slotkin BryanDirector | 33,052 |
| Custin AnnDirector | 24,626 |
| Gillin LeslieDirector | 18,856 |
| Mansbach Samuel RossGeneral Counsel and CCO | 18,663 |
| Harris CassandraChief Financial Officer | 7,372 |
Questions about ESTA
What does Establishment Labs Holdings Inc. do?
Establishment Labs Holdings Inc. is a company in the Health care sector, listed on NASDAQ as ESTA. Its shares trade on NASDAQ under the ticker ESTA.
What is Establishment Labs Holdings Inc.'s net worth?
Establishment Labs Holdings Inc. has a market value (market cap) of $2B at the latest share price, and shareholders' equity of $15.6M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Establishment Labs Holdings Inc. profitable?
No. Over the twelve months to September 30, 2026 it reported a net loss of $38.5M on revenue of $264M.
How much revenue does Establishment Labs Holdings Inc. make?
Over the twelve months to September 30, 2026 Establishment Labs Holdings Inc. reported revenue of $264M. That is 38.3% more than a year earlier.
When did Establishment Labs Holdings Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on November 6, 2026. It covers the period to September 30, 2026.
When is Establishment Labs Holdings Inc.'s next earnings report?
Establishment Labs Holdings Inc.'s next report is expected around January 11, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare ESTA with
Follow ESTA
Get an email when Establishment Labs Holdings Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Establishment Labs Holdings Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.